ALDH7A1 and cancer: PDEs overexpression has been already described in several cancer types (52–61); and their pharmacological inhibition has been shown to affect progression, migration, angiogenesis and differentiation in a large spectrum of tumor cells suggesting a potential application of PDE inhibitors as anticancer agents (62).